D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 81 Citations 27,570 241 World Ranking 11275 National Ranking 5908

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Disease
  • Parkinson's disease

Andrew Siderowf focuses on Psychiatry, Internal medicine, Disease, Parkinson's disease and Impulse control disorder. His Psychiatry study integrates concerns from other disciplines, such as Cronbach's alpha, Dementia and Audiology. His Internal medicine research is multidisciplinary, incorporating elements of Gastroenterology, Placebo and Neurology.

His Disease study incorporates themes from Biomarker and Bioinformatics. His Parkinson's disease research incorporates themes from Physical therapy, Severity of illness and Rating scale. Andrew Siderowf interconnects Movement disorders, Punding and Dopamine dysregulation syndrome in the investigation of issues within Impulse control disorder.

His most cited work include:

  • Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. (2766 citations)
  • Projected number of people with parkinson disease in the most populous nations, 2005 through 2030 (1549 citations)
  • Impulse Control Disorders in Parkinson Disease: A Cross-Sectional Study of 3090 Patients (993 citations)

What are the main themes of his work throughout his whole career to date?

Andrew Siderowf mainly focuses on Parkinson's disease, Disease, Internal medicine, Dementia and Psychiatry. His Parkinson's disease study combines topics in areas such as Central nervous system disease, Neuroscience, Depression, Gerontology and Physical therapy. His research in Physical therapy intersects with topics in Clinical trial and Rating scale.

His work deals with themes such as Pediatrics, Bioinformatics and Intensive care medicine, which intersect with Disease. His Internal medicine research includes themes of Gastroenterology and Oncology. His Psychiatry study combines topics in areas such as Movement disorders and Impulse control disorder.

He most often published in these fields:

  • Parkinson's disease (48.79%)
  • Disease (37.50%)
  • Internal medicine (30.24%)

What were the highlights of his more recent work (between 2016-2021)?

  • Internal medicine (30.24%)
  • Parkinson's disease (48.79%)
  • Cohort (10.48%)

In recent papers he was focusing on the following fields of study:

His primary scientific interests are in Internal medicine, Parkinson's disease, Cohort, Disease and Dementia. His biological study spans a wide range of topics, including Gastroenterology and Oncology. Andrew Siderowf has researched Parkinson's disease in several fields, including Dopaminergic, Cerebrospinal fluid and Physical therapy.

His study in Cohort is interdisciplinary in nature, drawing from both Psychiatry, REM sleep behavior disorder, Montreal Cognitive Assessment and Hazard ratio. Andrew Siderowf specializes in Disease, namely Movement disorders. His Dementia research is multidisciplinary, incorporating perspectives in Alzheimer's disease, Cognition, Effects of sleep deprivation on cognitive performance and Audiology.

Between 2016 and 2021, his most popular works were:

  • Neurodegenerative disease concomitant proteinopathies are prevalent, age-related and APOE4-associated (183 citations)
  • Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition. (176 citations)
  • 18F-flortaucipir tau positron emission tomography distinguishes established progressive supranuclear palsy from controls and Parkinson disease: A multicenter study (85 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Disease
  • Parkinson's disease

His scientific interests lie mostly in Internal medicine, Alzheimer's disease, Cohort, Cognition and Dopamine transporter. His Internal medicine research integrates issues from Positron emission tomography, Endocrinology and Oncology. His Cognition study incorporates themes from Dementia, Audiology and Pathology.

His Dopamine transporter research is multidisciplinary, incorporating elements of Cohort study, Psychiatry, Movement disorders and Parkinson's disease. His work focuses on many connections between Movement disorders and other disciplines, such as Rating scale, that overlap with his field of interest in Disease. His research is interdisciplinary, bridging the disciplines of Dopaminergic and Parkinson's disease.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results.

Christopher G. Goetz;Barbara C. Tilley;Stephanie R. Shaftman;Glenn T. Stebbins.
Movement Disorders (2008)

4583 Citations

Projected number of people with parkinson disease in the most populous nations, 2005 through 2030

E. R. Dorsey;R. Constantinescu;R. Constantinescu;J. P. Thompson;K. M. Biglan.
Neurology (2007)

1960 Citations

Impulse Control Disorders in Parkinson Disease: A Cross-Sectional Study of 3090 Patients

Daniel Weintraub;Juergen Koester;Marc N. Potenza;Andrew D. Siderowf.
JAMA Neurology (2010)

1487 Citations

The Parkinson Progression Marker Initiative (PPMI)

Kenneth Marek;Danna Jennings;Shirley Lasch;Andrew Siderowf.
Progress in Neurobiology (2011)

1097 Citations

Association of dopamine agonist use with impulse control disorders in Parkinson disease.

Daniel Weintraub;Andrew D. Siderowf;Marc N. Potenza;Joseph Goveas.
JAMA Neurology (2006)

784 Citations

A controlled trial of rasagiline in early Parkinson disease: The tempo study

Andrew Siderowf;Matthew Stern;Ira Shoulson;Karl Kieburtz.
JAMA Neurology (2002)

638 Citations

Validation of the Questionnaire for Impulsive-Compulsive Disorders in Parkinson's Disease

Daniel Weintraub;Staci Hoops;Judy A. Shea;Judy A. Shea;Kelly E. Lyons.
Movement Disorders (2009)

461 Citations

Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases.

Hanae Nakashima-Yasuda;Kunihiro Uryu;John Robinson;Sharon X. Xie.
Acta Neuropathologica (2007)

429 Citations

Impulse control disorders in parkinson disease: A multicenter case–control study

Valerie Voon;Mandy Sohr;Anthony E. Lang;Marc N. Potenza.
Annals of Neurology (2011)

414 Citations

Montreal Cognitive Assessment Performance in Patients with Parkinson’s Disease with “Normal” Global Cognition According to Mini-Mental State Examination Score

Sarra Nazem;Andrew D. Siderowf;John E. Duda;Tom Ten Have.
Journal of the American Geriatrics Society (2009)

408 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Andrew Siderowf

Daniel Weintraub

Daniel Weintraub

University of Pennsylvania

Publications: 185

John Q. Trojanowski

John Q. Trojanowski

University of Pennsylvania

Publications: 151

Daniela Berg

Daniela Berg

Kiel University

Publications: 142

Pablo Martinez-Martin

Pablo Martinez-Martin

Instituto de Salud Carlos III

Publications: 108

Werner Poewe

Werner Poewe

Innsbruck Medical University

Publications: 105

Anthony E. Lang

Anthony E. Lang

University of Toronto

Publications: 102

Bastiaan R. Bloem

Bastiaan R. Bloem

Radboud University Nijmegen

Publications: 99

Dag Aarsland

Dag Aarsland

King's College London

Publications: 94

K. Ray Chaudhuri

K. Ray Chaudhuri

King's College London

Publications: 87

David J. Burn

David J. Burn

Newcastle University

Publications: 85

David J. Brooks

David J. Brooks

Newcastle University

Publications: 85

Michael S. Okun

Michael S. Okun

University of Florida

Publications: 78

Andrew J. Lees

Andrew J. Lees

University College London

Publications: 76

Henrik Zetterberg

Henrik Zetterberg

University of Gothenburg

Publications: 74

Nir Giladi

Nir Giladi

Tel Aviv University

Publications: 73

Christopher G. Goetz

Christopher G. Goetz

Rush University Medical Center

Publications: 73

Trending Scientists

Jan Sijbers

Jan Sijbers

University of Antwerp

mike davies

mike davies

University of Edinburgh

Chen-Ching Liu

Chen-Ching Liu

Virginia Tech

Feng Wu

Feng Wu

University of Science and Technology of China

Amrit Tiwana

Amrit Tiwana

University of Georgia

Matteo Cianchetti

Matteo Cianchetti

Sant'Anna School of Advanced Studies

Rodolphe Clérac

Rodolphe Clérac

Paul Pascal Research Center

Prasat Kittakoop

Prasat Kittakoop

Chulabhorn Graduate Institute

Joseph C. Burns

Joseph C. Burns

North Carolina State University

Stephan Kempe

Stephan Kempe

Technical University of Darmstadt

Hanna E. Manninen

Hanna E. Manninen

Helsinki Region Environmental Services Authority

Abraham Zangen

Abraham Zangen

Ben-Gurion University of the Negev

John J. Miles

John J. Miles

James Cook University

Leonie S. Taams

Leonie S. Taams

King's College London

Thomas R. O'Brien

Thomas R. O'Brien

National Institutes of Health

Daniel J. Schaid

Daniel J. Schaid

Mayo Clinic

Something went wrong. Please try again later.